Indra Tumur

Summary

Affiliation: University of Sheffield
Country: UK

Publications

  1. ncbi Computerised cognitive behaviour therapy for obsessive-compulsive disorder: a systematic review
    Indra Tumur
    School of Health and Related Research, University of Sheffield, Sheffield, UK
    Psychother Psychosom 76:196-202. 2007
  2. ncbi Estimating the health benefits and costs associated with ezetimibe coadministered with statin therapy compared with higher dose statin monotherapy in patients with established cardiovascular disease: results of a Markov model for UK costs using data regis
    Roberta Ara
    Health Economics and Decision Science, School of Health and Related Research, University of Sheffield, Sheffield, United Kingdom
    Clin Ther 30:1508-23. 2008
  3. ncbi Cost effectiveness of ezetimibe in patients with cardiovascular disease and statin intolerance or contraindications: a Markov model
    Roberta Ara
    Health Economics and Decision Science, ScHARR, University of Sheffield, Regent Court, 30 Regent Street, Sheffield S1 4DA, UK
    Am J Cardiovasc Drugs 8:419-27. 2008

Detail Information

Publications3

  1. ncbi Computerised cognitive behaviour therapy for obsessive-compulsive disorder: a systematic review
    Indra Tumur
    School of Health and Related Research, University of Sheffield, Sheffield, UK
    Psychother Psychosom 76:196-202. 2007
    ..This paper summarises the available published evidence that assesses the effectiveness of a computerised cognitive behaviour therapy (CCBT) for obsessive-compulsive disorder (OCD)...
  2. ncbi Estimating the health benefits and costs associated with ezetimibe coadministered with statin therapy compared with higher dose statin monotherapy in patients with established cardiovascular disease: results of a Markov model for UK costs using data regis
    Roberta Ara
    Health Economics and Decision Science, School of Health and Related Research, University of Sheffield, Sheffield, United Kingdom
    Clin Ther 30:1508-23. 2008
    ..Ezetimibe has been reported to improve lipid control in patients with established cardiovascular disease (CVD)...
  3. ncbi Cost effectiveness of ezetimibe in patients with cardiovascular disease and statin intolerance or contraindications: a Markov model
    Roberta Ara
    Health Economics and Decision Science, ScHARR, University of Sheffield, Regent Court, 30 Regent Street, Sheffield S1 4DA, UK
    Am J Cardiovasc Drugs 8:419-27. 2008
    ..To evaluate the cost effectiveness of long-term ezetimibe monotherapy in patients with established cardiovascular disease (CVD) who do not tolerate statins or in whom they are contraindicated...